ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Tevogen Bio Holdings Inc

Tevogen Bio Holdings Inc (TVGN)

1.38
0.00
(0.00%)
Closed 24 January 8:00AM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.38
Bid
1.38
Offer
1.40
Volume
-
0.00 Day's Range 0.00
0.2556 52 Week Range 21.09
Market Cap
Previous Close
1.38
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,553,024
Shares Outstanding
175,051,247
Dividend Yield
-
PE Ratio
-11,275.00
Earnings Per Share (EPS)
-0
Revenue
-
Net Profit
-67k

About Tevogen Bio Holdings Inc

Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.

Sector
Biological Pds,ex Diagnstics
Industry
Blank Checks
Headquarters
Wilmington, Delaware, USA
Founded
2024
Tevogen Bio Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TVGN. The last closing price for Tevogen Bio was US$1.38. Over the last year, Tevogen Bio shares have traded in a share price range of US$ 0.2556 to US$ 21.09.

Tevogen Bio currently has 175,051,247 shares in issue. The market capitalisation of Tevogen Bio is US$241.57 million. Tevogen Bio has a price to earnings ratio (PE ratio) of -11275.00.

TVGN Latest News

Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference

WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (β€œCompany” or β€œTevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Host Panel Discussions β€œAI In Biopharma: Next Frontier of Medical Innovation” and β€œPioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference

The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies...

Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Host Panel β€œPioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame

WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi, CEO of Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech...

Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy

WARREN, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model

Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1512.19512195121.231.381.2058753601.31784059CS
40.3432.69230769231.041.570.989114423821.28444724CS
12-1.08-43.90243902442.462.63530.856525530241.39000402CS
260.6589.04109589040.733.090.255686694311.53876131CS
52-2.72-66.34146341464.121.090.255649478051.54883063CS
156-2.72-66.34146341464.121.090.255649478051.54883063CS
260-2.72-66.34146341464.121.090.255649478051.54883063CS

TVGN - Frequently Asked Questions (FAQ)

What is the current Tevogen Bio share price?
The current share price of Tevogen Bio is US$ 1.38
How many Tevogen Bio shares are in issue?
Tevogen Bio has 175,051,247 shares in issue
What is the market cap of Tevogen Bio?
The market capitalisation of Tevogen Bio is USD 241.57M
What is the 1 year trading range for Tevogen Bio share price?
Tevogen Bio has traded in the range of US$ 0.2556 to US$ 21.09 during the past year
What is the PE ratio of Tevogen Bio?
The price to earnings ratio of Tevogen Bio is -11.28k
What is the reporting currency for Tevogen Bio?
Tevogen Bio reports financial results in USD
What is the latest annual profit for Tevogen Bio?
The latest annual profit of Tevogen Bio is USD -67k
What is the registered address of Tevogen Bio?
The registered address for Tevogen Bio is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Tevogen Bio website address?
The website address for Tevogen Bio is www.tevogen.com/
Which industry sector does Tevogen Bio operate in?
Tevogen Bio operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 17.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.26
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.03
(0.00%)
0
AACGATA Creativity Global
US$ 0.9128
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.26
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.03
(0.00%)
0
AACGATA Creativity Global
US$ 0.9128
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.26
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.03
(0.00%)
0
AACGATA Creativity Global
US$ 0.9128
(0.00%)
0

TVGN Discussion

View Posts
glenn1919 glenn1919 6 days ago
TVGN....................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 2 weeks ago
TVGN.................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 3 weeks ago
TVGN....................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 1 month ago
TVGN...........................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Joe DiMaggio Joe DiMaggio 2 months ago
Buyback is on
πŸ‘οΈ0
oleskool oleskool 2 months ago
can this hit 2$ , gut says not gonna happen
πŸ‘οΈ0
tw0122 tw0122 2 months ago
See $4 zone ($4.20$4.54) as resistance now with the news eliminating debt and liabilities. Moves up slowly..
Tevogen reiterated its confidence in its financial stability, confirming sufficient available capital to fund operations for at least the next 33 months, supported by a loan agreement, which Tevogen entered into in June. Additionally, Tevogen eliminated almost all of its liabilities which were $99.9 million as reported at December 31, 2023 and now are $10.5 million as reported at September 30, 2024.





Tevogen’s internally developed intellectual property and product assets, valued internally at $10 billion+ using discounted cash flow models, are not reflected on the balance sheet. Due to US GAAP accounting rules, the company was unable to report the fair market value of its assets, including proprietary immunotherapy technologies and cutting-edge artificial intelligence platforms. The company believes that the inclusion of Tevogen’s IP assets on its balance sheet would significantly enhance its enterprise value



Commenting on the company’s performance and unique ownership structure, Dr. Saadi concluded, β€œTevogen’s leadership stands apart in the biotech sector, with approximately 78% of equity retained by our officers, an extraordinary figure compared to the industry average of just 4%. In addition to our officers, our key employees have also been granted substantial restricted stock units in the company, reflecting our belief that our employees should also be owners of our success.”





👍 1 🚀 1
glenn1919 glenn1919 2 months ago
TVGN.........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍 1 🔥 1
glenn1919 glenn1919 2 months ago
TVGN..........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
BurgerKing82 BurgerKing82 2 months ago
Looks interesting
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
TVGN..................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
👍️ 1
tw0122 tw0122 3 months ago
$1.32 + 10% .. WARREN, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, nears finalization of agreement with CD8 Technology for a turn-key facility intended to support both pre-clinical research and GMP manufacturing capabilities, staffed by Tevogen.
👍️ 1
OffTheGrid OffTheGrid 3 months ago
Adding 
πŸ‘οΈ0
HoldEm777 HoldEm777 3 months ago
https://www.stocktitan.net/news/TVGNW/tevogen-bio-expands-on-microsoft-partnership-to-integrate-machine-zepglnzxz4n7.html
πŸ‘οΈ0
BardRaider17 BardRaider17 3 months ago
Yes sir
πŸ‘οΈ0
getitrit getitrit 3 months ago
Is it true they are partners with Microsoft?
πŸ‘οΈ0
BardRaider17 BardRaider17 3 months ago
I think I messed up. I'm sitting on 555 @ average 2.58 I really did not want to be stuck in that overnight. Thoughts?
πŸ‘οΈ0
tw0122 tw0122 3 months ago
Flip out some $2.60s 
👍️ 1
tw0122 tw0122 3 months ago
Back in $2.20s for a flip maybe quick hopefully longer 
👍️ 1
tw0122 tw0122 3 months ago
Not much pumped some premarket so always careful have to see if $2.29- $2.47 zone holds afee profit taking then will add some perhaps 
πŸ‘οΈ0
BardRaider17 BardRaider17 3 months ago
Can you explain what that means for me? Im new TY
πŸ‘οΈ0
tw0122 tw0122 3 months ago
TVGN 3.20 trading float about 21m about 15m traded so far 
πŸ‘οΈ0
tw0122 tw0122 3 months ago
TVGN $4s coming will trade whole float by 930am
πŸ‘οΈ0
tw0122 tw0122 3 months ago
Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This WeekOctober 22 2024 - 2:30PM


Tevogen Bio (β€œTevogen” or β€œTevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to provide further updates on the previously announced revenue forecast for Tevogen Oncology and Tevogen Specialty Care therapeutic areas by the end of this week. The revenue forecast for the two therapeutic areas is approximately $1 billion each in their respective launch years. The 5-year combined estimate for the two therapeutic areas is between $28 billion and $36 billion.Tevogen Bio also plans to update shareholders on Tevogen AI, its proprietary artificial intelligence effort, designed to advance a mission to lower the total cost of drug development, expedite drug discovery, and deliver life-changing therapies to large patient populations. In addition, Tevogen Bio will provide an update on clinical and commercial manufacturing.
πŸ‘οΈ0
tw0122 tw0122 3 months ago
TVGN 3.75 -3.88 zone up there and then $4.27 on high side in the 2.62-3.40 zone for now
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
tvgn............................https://stockcharts.com/h-sc/ui?s=tvgn&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
dinogreeves dinogreeves 3 months ago
Actually buying more tomorrow, price targets changed 16-18 dollars by year end.
πŸ‘οΈ0
eur06 eur06 3 months ago
In less than 2 years CVNA went absolutely nuts wow!!!
TVGN
πŸ‘οΈ0
da_stock_analyst da_stock_analyst 3 months ago
#TVGN 🔥 70% short interest & $TVGN squeezing! watch this week!
πŸ‘οΈ0
frans frans 3 months ago
thanks
πŸ‘οΈ0
dinogreeves dinogreeves 3 months ago
SAVE could do similar pattern as CVNA did.
πŸ‘οΈ0
dinogreeves dinogreeves 3 months ago
For me personally not going to wait 10-12. I will sell at $6.00
πŸ‘οΈ0
frans frans 3 months ago
SAVE - when to 10 - 12 $ and who is selling all those shares?
πŸ‘οΈ0
dinogreeves dinogreeves 3 months ago
SAVE will run big 10-12 dollars
πŸ‘οΈ0
eur06 eur06 3 months ago
Wow uavs!!!!
save still ok ?
TVGN
πŸ‘οΈ0
dinogreeves dinogreeves 3 months ago
It was a great setup, I was looking for the Microsoft deal to come through and it did. Made my move on SAVE and UAVS.
πŸ‘οΈ0
dinogreeves dinogreeves 3 months ago
No loaded 4000 shares this morning, it should run to 7-8 dollars but it will get to 10-12 dollar range. Float is next to nothing. They have contracts with the French Army and the United Nations. Severly undervalued.
πŸ‘οΈ0
eur06 eur06 3 months ago
Wow that chart looks hot hot hot..lol
Just got some…waiting for updates?
TVGN
πŸ‘οΈ0
tw0122 tw0122 3 months ago
TVGN 2.90 time to flip this champ again. Happy trading 
πŸ‘οΈ0
dinogreeves dinogreeves 3 months ago
Buy UAVS too.
πŸ‘οΈ0
eur06 eur06 3 months ago
Great call dino…we’re making $$$ so far!!!!
OSS
πŸ‘οΈ0
tw0122 tw0122 3 months ago
MSFT deal $2.50 +50%
πŸ‘οΈ0
TimeFades TimeFades 3 months ago
Moon soon. A lot of headwinds
πŸ‘οΈ0
JUST 10-11-12 JUST 10-11-12 3 months ago
This should go much higher than five: "..... Dr. Saadi added, "I was pleased that Tevogen was able to provide updates on the Company, including our pipeline, our $1 billion launch year oncology guidance, and I expect to share more details on further progress in the coming days."....."
πŸ‘οΈ0
JUST 10-11-12 JUST 10-11-12 3 months ago
Got it
πŸ‘οΈ0
JUST 10-11-12 JUST 10-11-12 3 months ago
Why can I not uy Tvgn?
πŸ‘οΈ0
knrorrel knrorrel 3 months ago
SOUNDS AWESOME $TVGN IS READY
πŸ‘οΈ0
glenn1919 glenn1919 3 months ago
TVGN.............................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
SolarRevolution SolarRevolution 3 months ago
Showtime! Momentum , great news, and more news this week!

$$$

:)

Let’s do this !
πŸ‘οΈ0
StemCelzRock StemCelzRock 3 months ago
TVGN heading to $5.00 this week, don’t miss it. Nice PR!!!!!!!! Boom time.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock